Jaclyn Peterson - Mar 1, 2023 Form 4/A - Amendment Insider Report for CONMED Corp (CNMD)

Role: VP of Mfg. & Adv. Engineering
Signature: Sarah M. Oliker for Jaclyn Peterson by Power of Attorney
Stock symbol: CNMD
Transactions as of: Mar 1, 2023
Transactions value $: -$8,654
Form type: 4/A - Amendment
Date filed: 3/3/2023, 08:55 AM
Date Of Original Report: Mar 1, 2023
Previous filing: May 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNMD	Common Stock	Options Exercise	$0	+250	+43.18%	$0.00	829	Mar 1, 2023	Direct
transaction	CNMD	Common Stock	Tax liability	-$8.65K	-90	-10.86%	$96.16	739	Mar 1, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNMD	Rsus (restricted Stock Units)	Options Exercise	$0	-250	-25%	$0.00	750	Mar 1, 2023	Common Stock	250	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jaclyn Peterson is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.